ReviewEuropean urology open science2025

Incidence and Risk of Thromboembolic and Cardiovascular Adverse Events with PARP Inhibitor Treatment in Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Safety Meta-analysis.

Brigida Anna Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.